Welltech Ventures

Welltech Ventures is a small fund in Tel Aviv that decided early not to pretend it covered all of digital health. It backs Israeli startups building products in proactive health tracking, nutrition, mental health, and adjacent wellness categories, and it leaves the rest of the sector to firms with a different stomach for clinical risk and reimbursement timelines.

The thesis treats wellness as a global consumer software market that happens to overlap with healthcare rather than the other way around. That framing pushes the fund toward founders building direct-to-consumer products, prosumer tools, B2B2C plays through employers and insurers, and AI-driven personalization in areas like sleep, fitness, women’s health, metabolic health, and mental wellbeing. The portfolio reflects an appetite for repeat-purchase economics, real engagement metrics, and brand-driven distribution, with AI used as a means of making the product genuinely better rather than as a positioning line. Welltech is comfortable when the moat is data, behavioral design, and unit economics rather than regulatory exclusivity.

Checks fall in the one to five million dollar range, written at Seed and Series A. The fund will lead at Seed and is willing to play a meaningful role in a Series A syndicate where an earlier conviction has carried over. Geography centers on Israeli founders, almost always with global ambitions from launch, and the fund is comfortable with US, European, and Asian go-to-market plans depending on the category. The bar for diligence is heavy on consumer metrics, with cohort analysis and channel economics treated as load-bearing rather than supporting evidence.

The team is intentionally compact and operates with a hands-on cadence rather than the polite quarterly check-in some founders learn to expect from larger generalist funds. Founders interact directly with partners on the deals they care about, and the firm’s specialization means conversations skip the basics that consumer wellness pitches usually have to walk a generalist VC through. The fund has built an operator network across the wellness sector globally that it pulls into diligence and post-investment introductions.

The operating support is concentrated where wellness companies usually struggle: paid acquisition discipline, retention mechanics, partnership development with employers and payers, and the messy work of building a wellness brand that survives beyond the first viral moment. Welltech is direct about the categories it does not chase, including therapeutics, devices that depend on FDA clearance pathways, and clinical software targeting health systems. For founders building wellness products with a real consumer thesis and meaningful AI in the loop, it is one of the few specialist funds in the region with both the focus and the check size to lead a round. Expect a partner who understands the difference between a wellness app and a clinical product, who will push on retention curves rather than on TAM slides, and who will engage with the substance of the product rather than the deck wrapped around it.